Serum AST, ALT, and LDL-C levels in the HF group were significantly higher than in the control group (P<0.001, Figure 2 A, B, and D), and HDL-C was significantly lower in the HF group (P<0.001, Figure 2 C); while, after treatment with saroglitazar, diosmin, and the combination of saroglitazar and diosmin, levels of AST, ALT, and LDL-C showed a significant decrease compared to the HF group. The gene discussed is GPT; the disease is hydrops fetalis.